Abbreviation	Full Name
AGS cells	Atypical Glandular Cells
AKT Ser/Thr	Serine/threonine protein kinase B
AP-1	Activator protein-1
B cells	B lymphocytes
Bax	BCL2 Associated X
BBRF2	EBV homologues to herpes simplex virus capsid-associated or tegument components UL7
BCRF1	Viral interleukin-10 homolog
BHRF1	Bam HI fragment rightward open reading frame 1
BIM	BES1-interacting Myc-like protein
BL	EBV-positive Burkitt lymphomas
BLLF1	Glycoprotein 350/220
BMRF2	Epstein-Barr Virus DNA Polymerase Processivity Factor
BNRF1	Gene encoding for p140
BRLF-1	Replication and transcription activator
BZLF-1	Bam HI Z fragment leftward open reading frame 1
CAR T cell therapy	Chimeric antigen receptor T cell therapy
CD21 or CR2	Cluster of differentiation 21
CD35 or CR1	Cluster of differentiation 35
CD 50 values	Concentration of a test substance decreasing the number of viable cells by 50%
CDK2	Cyclin-dependent kinase 2
Cdt1	Chromatin licensing and DNA replication factor 1
CHIKV	Chikungunya Virus
CTAR1	Carboxy-terminal activating region 1 of LMP1
DC	Conjugated dienes
EA-D	Early antigen diffuse
EBER1	Epstein-Barr virus noncoding small RNA
EBER2	Epstein-Barr virus noncoding small RNA 2
EBNA	Epstein–Barr nuclear antigen
EBNA1	Epstein–Barr nuclear antigen 1
EBNA2	Epstein–Barr nuclear antigen 2
EBNA3A	Epstein–Barr nuclear antigen 3 A
EBNA3C	Epstein–Barr nuclear antigen 3 C
EBNA-LP	Epstein-Barr virus nuclear antigen leader protein
EBVaGC cells	Epstein-Barr virus-associated gastric carcinoma
EBV-EA	Epstein-Barr virus early antigen
EC50 value	Half maximal effective concentration
EGCG	Epigallocatechin-3-gallate
EGFR	Epidermal 237 growth factor receptor
EMA	European Medicines Agency
EphA2	Ephrin type-A receptor 2
FDA	Food and Drug Administration
Fp	F promoter
G1/S	Phases of the Cell Cycle
GADD45a	Growth arrest and DNA-damage-inducible protein
gB	Glycoprotein B
GC	Germinal center reaction
gH	Glycoprotein H
gL	Glycoprotein L
GL	Glycyrrhizic acid
gp350	EBV envelope glycoprotein 350
gp42	EBV envelope glycoprotein 42
HCV	Hepatitis C virus
HeLa cells	Cells from Lacks’s cancerous cervical tumor
HK1-EBV cells	Positive EBV nasopharyngeal carcinomas cells
HL	Hodgkin lymphoma
HLA	Human leukocyte antigen
HONE1	Positive EBV nasopharyngeal carcinomas cells
HSV	Herpes Simplex
IC50 values	Half maximal inhibitory concentration
IE	Immediate-early lytic genes
IL-10	Interleukin 10
IL-8	Interleukin 8
JAK/STAT	Janus kinases/signal transducer and activator of transcription proteins
JNK	C-Jun N-terminal kinase
JQ1	Bromodomain and Extra-terminal Inhibitor
LCLs	Lymphoblastoid cell lines
LMP1	Latent Membrane Protein 1
LMP2A	Latent Membrane Protein 2
MAPKs	Mitogen-activated protein kinases
MDA	Malondialdehyde
MS	Multiple sclerosis
mTORC2	Rapamycin complex 2
MYC	Master Regulator of Cell Cycle Entry and Proliferative Metabolism
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NPC	Nasopharyngeal Carcinoma
NRP1	Neuropilin 1
ORC2	Origin Recognition Complex subunit 2
p14ARF	Tumor suppressor p14
p16INK4a	Cyclin-dependent kinase inhibitor 2A
p38 MAPK	p38 MAP Kinase
P3HR1	EBV-positive Burkitt’s lymphoma cells
p53	Protein 53
p53 mutant B95.8 cells	Lymphoblastoid cell line with mutated protein 53
PAA	Phosphonoacetic acid
PARP	Poli ADP-ribosio polimerasi
PI3K/Akt	Phosphatidylinositol-3-kinase/ Protein kinase B
PMA	Phorbol 12-myristate 13-acetate
PKCα	Protein kinase Cα
p-STAT3	Phosphorylated signal transducer and activator of transcription 3
PUMA	p53 upregulated modulator of apoptosis
Raji cells	human B lymphoblastoid cell line
Rb	Retinoblastoma gene
ROS	Reactive oxygen species
Rta	Replication and transcription activator
SNU719 cells	Gastric cancer cell lines
TET2	Tet methylcytosine dioxygenase 2
TGF-β	Transforming growth factor beta
TPA	12-O-tetradecanoylphorbol-13-acetate
TRAF1	Tumor necrosis factor Receptor Associated Factor 1
VEGF	Vascular endothelial growth factor
XAF1	X-linked inhibitor of apoptosis protein associated factor 1